Category Archives: Uncategorized
Neurocrine Tardive Dyskinesia Drug Enters Phase II of Clinical Trials
On Sept. 19, 2011, Neurocrine Biosciences Inc. announced that phase II clinical trial of a new drug to treat tardive …
Reglan Linked to Tardive Dyskinesia, Says FDA
Patients treated with Reglan® should be aware of the risk of tardive dyskinesia, and should visit their doctors right away …
FDA Petitioned to Change Regulations for Generic Drug Makers
The consumer advocacy group, Public Citizen, is urging the FDA to revise regulations that prevent generic drug makers from changing …